China Resources Gas Group Ltd (1193)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 16.49 |
|---|---|
| 52-week range | 14.28 – 22.16 |
| Return, 1 month / 3 months | +1.2% / +6.2% |
| Return, 1 year / 3 years | −13.4% / −18.5% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 22.7% |
| Worst drawdown (1 year) | -34.4% |
| Average daily value traded | 51.65M HKD |
| Dividend yield | 5.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Resources Gas Group distributes and sells natural gas through piped networks in cities across China. It serves households, commercial businesses and industrial users, and also provides connection services and sells gas appliances and related equipment. The company is part of the China Resources group and is based in Hong Kong, with its gas operations concentrated in mainland Chinese cities where it holds local distribution concessions.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 1193, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Resources Gas Group Ltd (1193) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 16.49 on 20 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 390 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.4% and over the last three months it rose 6.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -6.6% | ||
| From 52-week high | -24.9% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.2% | ||
| 6-month return | -7.5% | ||
| 12-month return, skipping the last month | -14.4% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.4% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 51.65M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 59 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | +1.2% |
| 3 months | +6.2% |
| 6 months | −7.5% |
| 1 year | −13.4% |
| 3 years | −18.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 16.21 / 17.65 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Sep 2026 | HKD 0.3000 |
| 1 Jun 2026 | HKD 0.6500 |
| 10 Sep 2025 | HKD 0.3000 |
| 30 May 2025 | HKD 0.7000 |
| 12 Sep 2024 | HKD 0.2500 |
| 28 May 2024 | HKD 1.0069 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.